Thursday, 5 November 2026European Markets

OKEANIS ECO TANKER And ODFJELL SER. B Have A High Dividend Yield And Return On Equity In The Marine Shipping Industry.

Loading stream...

(VIANEWS) - OKEANIS ECO TANKER (OET.OL) is among this list of stock assets with the highest dividend rate and return on equity on the Marine Shipping industry.

Financial Asset Price Forward Dividend Yield Return on Equity
OKEANIS ECO TANKER (OET.OL) kr230.00 15.15% 31.71%
ODFJELL SER. B (ODFB.OL) kr88.20 9.9% 27.96%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. OKEANIS ECO TANKER (OET.OL)

15.15% Forward Dividend Yield and 31.71% Return On Equity

Okeanis Eco Tankers Corp., a tanker company, engages in the ownership, chartering and operation of oil tanker vessels worldwide. The company also provides various shipping services, such as technical support, maintenance, and insurance consulting services. It operates a fleet of six modern scrubber-fitted Suezmax tankers and eight modern scrubber-fitted VLCC tankers. The company was incorporated in 2018 and is based in Piraeus, Greece.

Earnings Per Share

As for profitability, OKEANIS ECO TANKER has a trailing twelve months EPS of kr41.92.

PE Ratio

OKEANIS ECO TANKER has a trailing twelve months price to earnings ratio of 5.49. Meaning, the purchaser of the share is investing kr5.49 for every norwegian krone of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 31.71%.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Jun 1, 2023, the estimated forward annual dividend rate is 36.51 and the estimated forward annual dividend yield is 15.15%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, OKEANIS ECO TANKER's stock is considered to be overbought (>=80).

More news about OKEANIS ECO TANKER.

2. ODFJELL SER. B (ODFB.OL)

9.9% Forward Dividend Yield and 27.96% Return On Equity

Odfjell SE engages in the transportation and storage of bulk liquid chemicals, acids, edible oils, and other special products. The company operates Chemical Tankers and Tank Terminals segments. It owns and operates chemical tankers that offers global and regional transportation; and tank terminals, which provides storage of various chemical and petroleum products. As of December 31, 2022, it operated a chemical tanker fleet of 69 vessels, including 46 owned, 6 bareboat chartered, 14 time chartered vessels, and 3 pool vessels. The company's terminal network comprises of 450 tanks with 1.2 million cubic meters of storage capacity. It operates in Norway, the Netherlands, rest of Europe, North America, South America, the Middle East, Asia, Australasia, and Africa. Odfjell SE was founded in 1914 and is headquartered in Bergen, Norway.

Earnings Per Share

As for profitability, ODFJELL SER. B has a trailing twelve months EPS of kr20.

PE Ratio

ODFJELL SER. B has a trailing twelve months price to earnings ratio of 4.41. Meaning, the purchaser of the share is investing kr4.41 for every norwegian krone of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 27.96%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ODFJELL SER. B's stock is considered to be overbought (>=80).

Volume

Today's last reported volume for ODFJELL SER. B is 1210 which is 79.91% below its average volume of 6024.

More news about ODFJELL SER. B.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,549 source documents archived
Query this data → isubstrate.com